Correlation of Transrectal Ultrasonography Guided Prostate Biopsy Gleason Score Results with Prostate Volume in Patients with Prostate Specific Antigen Level Between 2.5-10 ng/mL-Reference-Cited by-同舟云学术

Correlation of Transrectal Ultrasonography Guided Prostate Biopsy Gleason Score Results with Prostate Volume in Patients with Prostate Specific Antigen Level Between 2.5-10 ng/mL

Published:2024-09-03 Issue: Volume: Page:164-172
ISSN:2148-9580
Container-title:Journal of Urological Surgery
language:
Short-container-title:jus

Author:

Bostancı Coşkun,Erdem Kazım

Publisher

Galenos Yayinevi

Reference28 articles.

1. 1. Frost JM, Smith LA, Sharma P, de Riese WT. Possible clinical implications of peripheral zone changes depending on prostate size. Int Urol Nephrol. 2019;51:1721-1726. [Crossref]

2. 2. Orbe Villota PM, Leiva Centeno JA, Lugones J, Minuzzi PG, Varea SM. Comparison between the European Randomized Study for Screening of Prostate Cancer (ERSPC) and Prostate Biopsy Collaborative Group (PBCG) risk calculators: Prediction of clinically significant Prostate Cancer risk in a cohort of patients from Argentina. Actas Urol Esp (Engl Ed). 2024;48:210-217. [Crossref]

3. 3. EAU Guidelines on Prostate Cancer - Uroweb. In: Uroweb - European Association of Urology. https://uroweb.org/guidelines/prostate-cancer.Accessed 14 Apr 2023. [Crossref]

4. 4. Pagniez MA, Kasivisvanathan V, Puech P, Drumez E, Villers A, Olivier J. Predictive Factors of Missed Clinically Significant Prostate Cancers in Men with Negative Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis. J Urol. 2020;204:24-32. [Crossref]

5. 5. Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018;319:1914-1931. [Crossref]